Luspatercept for CIA in AML

NCT07663864 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-inducing Anemia

Interventions

DRUG: Luspatercept Injectable Product

Sponsor

Guangdong Second Provincial General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]